Bavarian Nordic A / S
Hellerup
- UEI
- D2WABKK2LYX4
- CAGE
- R5853
- SAM.gov registration
- Active through
Company facts
- FY2025 rankings
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Corporate family
-
-
- Durham, NC LA6TFGKSSFC1
-
- SAM.gov registration date
- Physical address
- Philip Heymans Alle 3, 2900 Hellerup, Denmark
- Website
- bavarian-nordic.com
- Founded
- 1994
- Employees
- 1K-5K
- Estimated annual revenue
- $250M-$500M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $143,520,504 |
| FY2024 | $222,920,840 |
| FY2023 | $125,545,488 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Evaluation of the safety and efficacy of a virus-like particle vaccine for prevention of chikungunya virus disease | Defense Health Agency | $1,757,856 |
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Corporate | Gaithersburg, MD | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Medigen, Inc. | Frederick, MD | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Inovio Pharmaceuticals, Inc. | Plymouth Meeting, PA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| DVC Segment | Frederick, MD | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| VIR Biotechnology, Inc. | San Francisco, CA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
About the company
Bavarian Nordic A / S is a biotechnology company focused on the development and manufacturing of cancer immunotherapies and vaccines for infectious diseases. Through long-standing collaborations, including with the U.S. government, the company has developed proprietary technologies and expertise in vaccine development and manufacturing.
Bavarian Nordic A / S has provided various goods and services to the federal government through prime contract awards. These include endpoint titer analysis services involving proprietary assays and techniques like enzyme-linked immunosorbent assay and plaque reduction neutralization testing to support vaccine trials and research conducted by entities like the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID). The Defense Health Agency, Department of the Army Medical Command, and U.S. Army Medical Research Acquisition Activity have awarded these contracts, with no set-asides indicated.
Through a federal grant award from the Defense Health Agency, Bavarian Nordic A / S has conducted research on evaluating the safety and efficacy of a virus-like particle vaccine for the prevention of Chikungunya virus disease. This $431,088.52 project grant supports efforts to develop medical countermeasures against infectious disease threats.
Bavarian Nordic A / S holds two indefinite delivery vehicles (IDVs) awarded by federal agencies. A $245,070 single-award IDC from the Defense Health Agency enables Bavarian Nordic to provide endpoint titer analysis services for USAMRIID's vaccine trials through September 2028, with a recent $45,000 delivery order issued. Additionally, the Department of the Army Acquisition Support Center's $92,082,766.38 Other Transaction Agreement IDV tasks Bavarian Nordic with prototyping activities to develop the Medical Viral Aerosol Wheeled Encapsulated Endotracheal Ventilator system and advance its Eastern equine encephalitis virus vaccine candidate through the Joint Project Manager for Medical Countermeasure Systems.
Quick answers
Is Bavarian Nordic A / S registered in SAM.gov?
Yes. Bavarian Nordic A / S's SAM.gov registration is active through February 27, 2027.
How much has Bavarian Nordic A / S received in federal contracts?
Federal contracts obligated $143,520,504 to Bavarian Nordic A / S in fiscal year 2025 and $491,986,832 in fiscal years 2023 through 2027.
How does Bavarian Nordic A / S rank among federal contractors?
Bavarian Nordic A / S ranked #3 in NAICS 325412, #5 in NAICS 3254 and #5 in PSC 6505 in FY2025.
What is Bavarian Nordic A / S's most recent federal award?
Bavarian Nordic A / S's most recent federal contract award is End point titer analysis services for usamriid (HT942523F0374), from Defense Health Agency, on September 29, 2023.
On GovTribe
See Bavarian Nordic A / S's full federal record
- Federal contract awards
- IDV awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors